RUMORED BUZZ ON 9. MOUNJARO 7.5 MG INFORMATION

Counsel individuals regarding the prospective risk for MTC with using tirzepatide and inform them of indicators of thyroid tumors (e.g., a mass within the neck, dysphagia, dyspnea, persistent hoarseness). Plan monitoring of serum calcitonin or using thyroid ultrasound is of unsure value for early detection of MTC in clients treated with tirzepatide